GB virus type C/HGV markers in HCV RNA-positive French blood donors: correlation with HCV genotypes and risk factors.
BACKGROUND
Exposure to GB virus type C/HGV (GBV-C/HGV) could be determined by detection either of RNA by RT-PCR or of antibodies of the envelope protein E2.


METHODS
The aim of the study was to determine the proportion of the GBV-C/HGV markers of infection in a blood donor population infected with HCV and to identify GBV-C/HGV routes of transmission that are associated with HCV genotypes and risk factors.


RESULTS
Among 306 HCV RNA-positive blood donors, the proportion of GBV-C/HGV RNA-positive donors and anti-E2-positive donors was 19.3 percent (95% CI = 15.0-24.2%) and 42.1 percent (95% CI = 36.6-47.9%), respectively. Exposure to GBV-C/HGV (RNA or anti-E2) was significantly associated with the risk factor of IV drug use. There was a trend toward association with HCV subtypes 1a and 3a, probably because these HCV subtypes are the most frequent in IV drug users. No correlation was observed between ALT elevation and the presence of GBV-C/HGV RNA.


CONCLUSIONS
In persons with HCV infection, IV drug use seems to be a major route of GBV-C/HGV transmission. Precautions taken to avoid HCV infection will probably also decrease GBV-C/HGV transmission.
National Institute of Blood Transfusion, Paris, France.
F
F
Bouchardeau
S
S
Laperche
J
J
Pillonel
M H
MH
Elghouzzi
P
P
Maisonneuve
C
C
Tirtaine
E
E
Boiret
A
A
Razer
A
A
Girault
M J
MJ
Beaulieu
A M
AM
Couroucé
D015415:Biomarkers; D001782:Blood Donors; D018067:Flaviviridae / Q000235:genetics* / Q000302:isolation & purification*; D016174:Hepacivirus / Q000235:genetics* / Q000302:isolation & purification*; D006526:Hepatitis C / Q000517:prevention & control* / Q000635:transmission; D006525:Hepatitis, Viral, Human / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D012367:RNA, Viral / Q000302:isolation & purification*
D015415:Biomarkers; D012367:RNA, Viral